Effects of drospirenone on blood pressure and heart rate in rats measured by highly sensitive radiotelemetry

Gynecological Endocrinology

Volumn 10, Issue SUPPL. 2, 1996, Pages 183-185

  Krattenmacher, R ^a   Dobrindt, C ^a   Hegele Hartung, Ch ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Blood pressure; Drospirenone; Oral contraceptives

Indexed keywords

EID: 0342930881     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.3109/09513599609045657     Document Type: Article

References (3)

1. Muhn, P., Krattenmacher, R., Beier, S., Elger, W. and Schillinger, E. (1995). Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models. Contraception, 51, 99-110
2. Muhn, P., Fuhrmann, U., Fritzemeier, K.H., Krattenmacher, R. and Schillinger, E. (1995). Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Ann. N.Y. Acad. Sci., 761, 311-35
3. Fuhrmann, U., Krattenmacher, R., Slater, E.P. and Fritzemeier, K.H. (1996). The novel progestin drospirenone and its natural counterpart progesterone: antiandrogenic potential and biochemical profile. Contraception, submitted